BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 8442259)

  • 1. Acute interstitial nephritis of plasma cells: a new cause for renal allograft loss.
    David-Neto E; Ribeiro DS; Ianhez LE; Palomino S; Saldanha LB; Arap S; Sabbaga E
    Transplant Proc; 1993 Feb; 25(1 Pt 2):897-9. PubMed ID: 8442259
    [No Abstract]   [Full Text] [Related]  

  • 2. The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies.
    Meehan SM; Domer P; Josephson M; Donoghue M; Sadhu A; Ho LT; Aronson AJ; Thistlethwaite JR; Haas M
    Hum Pathol; 2001 Feb; 32(2):205-15. PubMed ID: 11230708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferation rate of cells in the interstitial infiltrate in acute kidney allograft rejection.
    Olsen S; Hansen HE
    Transplant Proc; 1996 Feb; 28(1):502-3. PubMed ID: 8644329
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunohistological study of a pediatric patient with plasma cell-rich acute rejection.
    Chikamoto H; Sugawara N; Akioka Y; Shimizu T; Horita S; Honda K; Moriyama T; Koike J; Yamaguchi Y; Hattori M
    Clin Transplant; 2012 Jul; 26 Suppl 24():54-7. PubMed ID: 22747477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose dexamethasone--an alternative therapy for acute renal allograft rejection.
    Kher V; Kohli HS; Mishra V; Sharma RK; Bhandari M
    Transplant Proc; 1992 Oct; 24(5):1725. PubMed ID: 1412812
    [No Abstract]   [Full Text] [Related]  

  • 6. Study of acute antibody-mediated rejection in renal allograft biopsies.
    Kanodia KV; Vanikar AV; Trivedi HL
    Transplant Proc; 2008 May; 40(4):1099-103. PubMed ID: 18555123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can a diagnosis of renal allograft rejection be based on histology alone?
    Midtvedt K; Hartmann A; Sund S
    Clin Transplant; 1998 Aug; 12(4):300-2. PubMed ID: 9686323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD45 isoforms and lymphocyte activation antigens in acute renal allograft rejection.
    Battochio A; Solez K; Poppema S; Cockfield S; Rayner D
    Transplant Proc; 1996 Feb; 28(1):482-3. PubMed ID: 8644320
    [No Abstract]   [Full Text] [Related]  

  • 9. Significance of interstitial lesions as the early indicator for acute vascular rejection in human renal allografts.
    Saisu K; Morozumi K; Suzuki K; Fujita K
    Clin Transplant; 1999; 13 Suppl 1():17-23. PubMed ID: 10751052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of first acute rejection episode and severity of rejection on cadaveric renal allograft survival.
    Hariharan S; Alexander JW; Schroeder TJ; First MR
    Clin Transplant; 1996 Dec; 10(6 Pt 1):538-41. PubMed ID: 8996775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of pretransplant antibodies on early renal allograft rejection.
    Alarif L; Rodriguez R; Blackburn S; Light JA
    Transplant Proc; 1987 Feb; 19(1 Pt 1):771-2. PubMed ID: 3274869
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of B lymphocytes (CD20+) in renal allograft biopsy specimens.
    Martins HL; Silva C; Martini D; Noronha IL
    Transplant Proc; 2007 Mar; 39(2):432-4. PubMed ID: 17362749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cells in cluster or in a scattered pattern do not correlate with clinical outcome of renal allograft rejection.
    Scheepstra C; Bemelman FJ; van der Loos C; Rowshani AT; van Donselaar-Van der Pant KA; Idu MM; ten Berge IJ; Florquin S
    Transplantation; 2008 Sep; 86(6):772-8. PubMed ID: 18813100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus therapy for refractory acute renal allograft rejection: a prospective multicenter trial. Tacrolimus Kidney Transplantation Rescue Study Group.
    Woodle ES; Thistlethwaite JR; Gordon JH
    Transplant Proc; 1996 Dec; 28(6):3163-4. PubMed ID: 8962225
    [No Abstract]   [Full Text] [Related]  

  • 15. Follow-up of patients with borderline changes in renal allograft biopsies: clinical outcome and evaluation of other histological features in addition to tubulitis.
    Papadimitriou J; Drachenberg C; Anderson L; Bartlett S; Johnson L; Klassen D; Hoehn-Saric E; Weir M; Schweitzer E
    Transplant Proc; 1996 Feb; 28(1):517-8. PubMed ID: 8644334
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-CD4 monoclonal antibody therapy of late acute rejection in renal allograft recipients--CD4+ T cells play an essential role in the rejection process.
    Reinke P; Kern F; Fietze E; Döcke WD; Ewert R; Emmrich F; Volk HD
    Transplant Proc; 1995 Feb; 27(1):859-62. PubMed ID: 7879207
    [No Abstract]   [Full Text] [Related]  

  • 17. Graft loss associated with late humoral rejection after renal transplantation.
    Sun Q; Li L
    Clin Transpl; 2006; ():521-5. PubMed ID: 18365417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late onset acute rejection of renal allografts, an indicator of suboptimum cyclosporin dosage.
    Sumethkul V; Jirasiritham S; Chiewsilp P
    Transplant Proc; 1996 Jun; 28(3):1461-2. PubMed ID: 8658741
    [No Abstract]   [Full Text] [Related]  

  • 19. Mast cells in acute cellular rejection of human renal allografts.
    Lajoie G; Nadasdy T; Laszik Z; Blick KE; Silva FG
    Mod Pathol; 1996 Dec; 9(12):1118-25. PubMed ID: 8972470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proceedings of the 12th Clinicopathological Conference on Renal Allograft Pathology, 19 July 2008, Tokyo, Japan. Introduction.
    Hattori M
    Clin Transplant; 2009 Aug; 23 Suppl 20():1. PubMed ID: 19594586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.